Search by Abstract Number Results

Abstract Number: 93 • 2019 ACR/ARP Annual Meeting
Interferon Pathway Activation in T Follicular Helper (Tfh) Cell Subsets in Human Myositis
Amrutesh Puranik¹, Mark Jensen ², Regine Tipon ³, Yogita Ghodke-Puranik ³, Valeria Mezzano ⁴, Shanmugapriya Selvaraj ⁵, Theresa Wampler Muskardin ⁴, Cynthia Loomis ⁴, Ann Reed ⁶, Lauren Pachman ⁷ and Timothy Niewold ⁵, ¹NYU Langone Health, New York, NY, ²Colton Center for Autoimmunity, NYU School of Medicine, New York, NY, ³Colton Center for Autoimmunity, NYU School of Medicine, New York, ⁴New York University Langone Health, New York, ⁵New York University Langone Health, New York, NY, ⁶Duke University School of Medicine, Durham, NC, ⁷Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
Background/Purpose: T and B cells come together in ectopic lymphoid aggregates in myositis, suggesting that local T:B cell interactions could play a role in disease. …
Abstract Number: 93 • 2018 ACR/ARHP Annual Meeting
Biomarkers Associating Endothelial Function in Systemic Lupus Erythematous
Wan-Fang Lee¹, Chao-Yi Wu², Huang-Yu Yang³ and Jing-Long Huang^2,4, ¹Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang-Gung Memorial Hospital, Taoyuan city, Taiwan, ²Division of Allergy, Asthma and Rheumatology. Department of Pediatrics, Chang-Gung Memorial Hospital, Taoyuan city, Taiwan, ³Department of Nephrology,, Chang-Gung Memorial Hospital, Taoyuan city, Taiwan, ⁴Medicine, Chang-Gung University, Taoyuan city, Taiwan
Background/Purpose: The endothelium is a key element in the regulation of vascular homeostasis and its alteration is a precursor of vascular disease. Considering SLE is…
Abstract Number: 93 • 2017 ACR/ARHP Annual Meeting
Peer-Developed E-Learning Resource Can Address Rheumatology Knowledge Gaps in Junior Learners
Larissa Petriw¹, Tabitha Kung² and Mala Joneja², ¹Internal Medicine, Queen's University, Kingston, ON, Canada, ²Rheumatology, Queen's University, Kingston, ON, Canada
Background/Purpose: The symptoms related to Rheumatologic diseases are responsible for one third of visits to general practitioners, yet medical students and residents remain inadequately prepared…
Abstract Number: 93 • 2017 Pediatric Rheumatology Symposium
Corticosteroid Regimen Use in the Pilot Study of Consensus Treatment Plans for Induction Therapy in Childhood Proliferative Lupus Nephritis
Jennifer C. Cooper¹, B. Anne Eberhard², Marilynn Punaro³, Stacy P. Ardoin⁴, Hermine Brunner⁵, Joyce Hsu⁶, Linda Wagner-Weiner⁷, Marisa Klein-Gitelman⁸, Kelly A. Rouster-Stevens⁹, Laura E. Schanberg¹⁰, Emily von Scheven¹¹ and the CARRA Investigators, ¹Pediatrics, Divison of Rheumatology, University of California, San Francisco, San Francisco, CA, ²Cohen Children's Medical Center of New York, New Hyde Park, NY, ³Texas Scottish Rite Hospital for Children, Dallas, TX, ⁴Pediatric & Adult Rheumatology, Ohio State University, Columbus, OH, ⁵Rheumatology, PRCSG, Cincinnati, OH, ⁶Pediatric Rheumatology, Stanford University, Palo Alto, CA, ⁷University of Chicago Hospital, Chicago, IL, ⁸Division of Rheumatology, Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, ⁹Pediatric Rheumatology, Emory Children's Center, Atlanta, GA, ¹⁰Pediatrics, Duke Medical Center, Durham, NC, ¹¹Division of Rheumatology, Department of Pediatrics, University of California San Francisco, San Francisco, CA
Background/Purpose: Comparative data in the pediatric lupus nephritis (LN) population are lacking. To reduce treatment variability and facilitate comparative effectiveness studies, the Childhood Arthritis and…
Abstract Number: 93 • 2016 ACR/ARHP Annual Meeting
2015 ACR/ARHP Workforce Study in the United States: Adult Rheumatologist Supply and Demand Projections for 2015-2030
Daniel Battafarano¹, Seetha Monrad², John Fitzgerald³, Marcy Bolster⁴, Chad Deal^5,6, Anne R. Bass⁷, Rodolfo Molina⁸, Alan R. Erickson⁹, Benjamin J Smith¹⁰, Karla B. Jones¹¹, Jonathan S. Hausmann¹², Val Gokenbach¹³, Kamilah Lewis¹⁴ and Marcia Ditmyer¹⁵, ¹Medicine, San Antonio Military Medical Center, San Antonio, TX, ²Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, ³Medicine, UCLA, Los Angeles, CT, ⁴Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ⁵Orthopedic and Rheumatology Institute, Cleveland Clinic Foundation, Cleaveland, OH, ⁶Dept of Rheum & Imm Dis /A 50, Cleveland Clinic Foundation, Cleveland, OH, ⁷Rheumatology, Hospital for Special Surgery, New York, NY, ⁸Arthritis Associates PA, San Antonio, TX, ⁹Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, ¹⁰Rheumatology, McIntosh Clinic, P.C., Thomasville, GA, ¹¹Rheumatology, Nationwide Children's, Columbus, OH, ¹²Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ¹³Academy for Academic Leadership, Detroit, MI, ¹⁴American College of Rheumatology, Atlanta, GA, ¹⁵Academy for Academic Research, Las Vegas, NV
Background/Purpose: The 2015 ACR Workforce study updated the current and projected adult rheumatology workforce for the next 15 years. Methods: The 2015 ACR/ARHP Workforce…
Abstract Number: 93 • 2015 ACR/ARHP Annual Meeting
An HLA-C Amino Acid Variant in Addition to HLA-B*27 Confers Risk for Ankylosing Spondylitis in the Korean Population
Kwangwoo Kim¹, So-Young Bang², Seunghun Lee³, Hye-Soon Lee², Seung-Cheol Shim⁴, Young Mo Kang⁵, Chang-Hee Suh⁶, Celi Sun⁷, Swapan Nath⁷, Sang-Cheol Bae² and Tae-Hwan Kim², ¹Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ²Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ³Department of Radiology, Hanyang University College of Medicine, Seoul Hospital, Seoul, South Korea, ⁴Division of Rheumatology, Daejeon Rheumatoid and Degenerative Arthritis Center, Chungnam National University, Daejeon, South Korea, ⁵Dept of Internal Medicine, Kyungpook National University School of Medicine, Daegu, South Korea, ⁶Allergy-Rheumatology, Ajou University School of Medicine, Suwon, South Korea, ⁷Oklahoma Medical Research Foundation, Oklahoma City, OK
Background/Purpose: Ankylosing spondylitis (AS) is a highly heritable rheumatic disease causing chronic inflammation of axial spine, joints and various organs. The presence of HLA-B*27 is…
Abstract Number: 93 • 2014 ACR/ARHP Annual Meeting
Protein Profiling of Secretome Human Cartilage to Identify Potential EARLY Specific Biomarkers in Osteoarthritis
Lucia Lourido, Valentina Calamia, Patricia Fernandez-Puente, Jesus Mateos, Francisco J. Blanco Garcia, Beatriz Rocha, Carolina Fernández-Costa, Carlos Fernandez-Lopez, Natividad Oreiro and Cristina Ruiz-Romero, Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A Coruña, Spain
Background/Purpose: Osteoarthritis (OA) is characterized by the progressive loss of cartilage structural extracellular matrix (ECM) components. The release of these proteins from the tissue can…
Abstract Number: 93 • 2013 ACR/ARHP Annual Meeting
Higher Consumption Of Sugar-Sweetened Soft Drinks Increases The Risk Of Hyperuricemia In Korean Population: The Korean Multi-Rural Communities Cohort Study
Seong-Kyu Kim¹, Jisuk Bae², Jung-Yoon Choe¹, Byung-Yeol Chun³, Pil Sook Park⁴ and Dong Hoon Shin⁵, ¹Catholic University of Daegu School of Medicine, Daegu, South Korea, ²Department of Preventive Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ³Kyungpook National University School of Medicine, Daegu, South Korea, ⁴Kyungpook National University, Daegu, South Korea, ⁵School of Medicine Keimyung University, Daegu, South Korea
Background/Purpose: The aim of this study is to clarify the association between sugar-sweetened soft drinks and fruit drinks made from oranges and apples and the…
Abstract Number: 93 • 2012 ACR/ARHP Annual Meeting
Health State Utilities in Systemic Sclerosis: Results From the UCLA Scleroderma Quality of Life Study
Mohsen Sadatsafavi¹, Dinesh Khanna², Paul Maranian³, Daniel Furst⁴, Amir Khakban¹ and Carlo A. Marra¹, ¹Pharm Sciences, Univ of British Columbia, Vancouver, BC, Canada, ²Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, ³Division of Rheumatology, UCLA Medical School, Los Angeles, CA, ⁴David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA
Background/Purpose: Health state utility values (HSUVs) are used as weightings for quality-adjusted life years (QALYs) in economic analyses. It is not clear whether available instruments…

Search Again »

Didn't find what you were looking for? Try the Advanced Search »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].